Brennan Marilla Email and Phone Number
Brennan Marilla's Location
Anna Maria, Florida, United States, United States
Brennan Marilla's Contact Details
Brennan Marilla work email
- Valid
- Valid
- Valid
- Valid
Brennan Marilla personal email
n/a
Brennan Marilla phone numbers
About Brennan Marilla
Brennan Marilla is a Chief Commercial & Operating Officer at OSSIO at OSSIO, Ltd.. They possess expertise in medical devices, sales operations, product launch, product management, cross functional team leadership and 29 more skills. Colleagues describe them as "I am writing to recommend Brennan Marilla. He is an outstanding sales and marketing leader. I worked with him in the Endovascular business at Medtronic. Brennan was able to lead and inspire our organization when we had great new products and when we had a long product gap. He is excellent at building relationships with customers, thinking strategically and leading and inspiring large teams. I think he is an excellent leader and I would highly recommend him to any organization." and "have known Brennan for over ten years and have worked with him while he was at both Medtronic and Covidien. I have always appreciated his strong leadership, creative marketing mind, and integrity. He is one of the most well known and well respected leaders in the vascular industry, and is very good at building relationships with key opinion leaders. He is widely recognized as one of the key industry leaders that helped to grow adoption of EVAR therapies to where it is today and his presence and work at Covidien certainly elevated the perception of their vascular business with me and many of my interventional colleagues. I enthusiastically endorse Brennan and look forward to continued collaboration with him."
Brennan Marilla's Current Company Details
Brennan Marilla Work Experience Details
-
Chief Commercial And Operating OfficerOssio, Ltd. Oct 2017 - PresentWoburn, Massachusetts, UsResponsibilities include sales, marketing, commercial operations, clinical research/affairs, and business development for early stage disruptive technology in the $15B+ orthopedic fixation implant space based in Woburn, MA and Caesarea, Israel.Ossio is an orthopedic start up founded in Israel with the vision to replace metal implants as the standard of care in the $15B+ orthopedic fixation market (screws, pins, plates) with an intelligent bone regeneration technology. OSSIOfiber represents a breakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient mobility with nothing permanent left behind. Our products have the mechanical strength needed for easy insertion and secure fixation while enabling the body to regrow bone, completely incorporating and replacing the implant without the adverse inflammation and weakness often seen in “bio-resorbables”.
-
Chief Commercial OfficerSurgical Specialties Corporation Dec 2014 - Sep 2017Westwood, Massachusetts, Us(now Corza Medical)Global sales and marketing leader for private $150M+ business focused on branded, private label, and OEM products for wound closure, ophthalmic, and biopsy markets sold via direct and distributor channels.• Key member of new executive team hired to turnaround underperforming business and prepare for sale.• Acquired by investor syndicate led by Vivo Capital & ZQ Capital- Mar '17. Tripled valuation in 2 years by:- Returning top line to high single digit growth after history of declining revenues while executing complex plant moves. - EBITDA growth of 70% via increased rev and margins, and op ex reductions. Acquired German needle manufacturer.- Relocated and rebuilt marketing team and sales operations in Boston. Strengthened key global sales leadership positions and reorganized US and China sales structure.- Led positive shifts in commercial strategies, rebranding, customer and employee engagement, and reimbursement.- Critical player in sell side acquisition process- Board & bank interactions, positioning, presentations, buyer diligence. Privately held Surgical Specialties Corporation (Angiotech) develops and manufactures surgical instruments for its own brands and as an original equipment manufacturer (OEM) for virtually every medical device company throughout the world. In the U.S., we sell our products using both direct sales reps and distributor partners. Outside of the US, we sell our products exclusively through distributor organizations. Offering one of the most comprehensive portfolios of blades and sutures available, including innovative products such as the Quill™ Knotless Tissue-Closure Device, the company devotes itself to exceeding the needs of the specialty surgery market, having trusted partnerships within dental, ophthalmic, plastic surgery, dermatology, orthopedics, urology, microsurgery, veterinary and trauma specialties. -
Vice President & General Manager, EndovascularCovidien May 2013 - Aug 2014Fridley, Minnesota, UsP&L responsibility and cross functional leadership of $650m market leading Global Business Unit focused on the endovascular treatment of peripheral arterial and venous diseases (formerly ev3 & VNUS). Promoted to GM after Peripheral Vascular reorganized into three franchises. - Co-sponsor of Stellarex Drug Coated Balloon Leadership Steering Committee. Executing 1500+ patient US IDE, EU randomized, PK, and Global Registry "Illumenate" clinical programs, full integration of CVIngenuity acquisition, and CE mark achievement for one of Covidien's top 5 strategic bets. - Exceeding BridgePoint Medical Peripheral acquisition pro forma metrics and achieved #1 US revenue share for Chronic Total Occlusion product family in less than 24 months from launch. - Closed and relocated San Jose, CA VNUS facility to Plymouth, MN while exceeding FY13 forecast and achieving double digit growth for this franchise. - Consolidated arterial and venous marketing into one unified MN based team. Added dedicated portfolio management, international, and market development functions to focus on global growth acceleration initiatives. - Dramatically reduced SG&A spend and increased core operating income via revenue growth, multiple product introductions and portfolio expansion programs, strategic commercial restructuring, and increasing employee engagement scores. - Completed strategic acquisition of Sapheon, Inc., a novel breakthrough treatment for Chronic Venous Insufficiency. - Completed Covidien Executive "Aspire" Program for high potential leaders. -
Vice President, Sales & Global Marketing- Peripheral VascularCovidien Mar 2012 - May 2013Fridley, Minnesota, UsChief commercial leader of $1.4B PV global business unit and 500 direct reports. Led integration of ev3 Peripheral Vascular and existing Covidien Venous franchises into one PV commercial organization.- Exceeded FY12 forecast despite complex integration of multiple commercial teams and cultures. - Provided strategic leadership and direction on creation of new value proposition, vision, branding and strategic plan for the GBU. Directed commercial diligence for several BD&L projects including CVIngenuity acquisition (novel drug coated PTA). Successfully launched acquired BridgePoint Medical Peripheral CTO Technologies globally.
-
Vice President, Sales & Global Marketing-Venous VascularCovidien Nov 2010 - Apr 2012Fridley, Minnesota, UsCommercial leadership of $700m Chronic Venous Insufficiency, Kendall Compression, and Dialysis franchises. - Reorganized Kendall, VNUS, Bacchus teams into a more cohesive, productive commercial organization. Drove significant operating leverage while improving customer facing organization. - Returned ClosureFast (VNUS) business to double digit growth through new talent acquisition, strategic shifts in investment and branding, and enhanced physician training programs. Introduced society endorsed market development initiatives including Rethink Varicose Veins patient awareness campaign. Signed Olympic Gold Medalist and TV personality Summer Sanders to serve as celebrity spokesperson. - Worked to reinvent mature compression business by entering adjacent home care market and driving multi-media awareness of DVT in pregnancy risk with society backed "1 in 1000" campaign, which won the Covidien Business Model Innovation Award.
-
Vice President Of Us Sales-EndovascularMedtronic Jan 2006 - Nov 2010Minneapolis, Mn, UsSales leader for $250m abdominal aortic aneurysm(AAA) and thoracic (TAA) endograft business and 187 direct sales personnel. Doubled revenue and EBIT and captured market leadership during tenure.- Developed annual operating and strategic plans to exceed revenue, profitability, and market penetration objectives. Grew ASP's during the last three years in the role via our value proposition of best in class service. - Consistently achieved highest sales function scores on annual MDT "Global Voices" employee survey for sales training, development, and engagement. - Key member of Portfolio Strategy Board and Product Review Committee. - Managed KOL relationships and developed unique service model to lead market in customer satisfaction. Helped create and launch innovative 3D CT Reconstruction procedure planning service. - Restructured and expanded US sales organization in '06, '08, and '10 to achieve growth targets and dramatically increase sales force productivity. Created Therapy Development Specialist position to drive targeted market development, patient awareness, and practice management initiatives. - Reversed dramatic AAA market share decline in FY06 to eventually double revenue and EBIT. Doubled headcount while driving exceptional profitability and operating leverage improvements (#2 most profitable MDT business). - Recaptured US AAA market leadership with launch of Talent AAA in FY09 and won market leadership in Thoracic space within 12 months of launch in FY10. Fastest growing US geography in FY09 (+48%).- Medtronic Star of Excellence Awards- Talent Commercialization Team & US Endo Sales Operations, 2009. - Cardiovascular Star of Excellence Award- CT Express film review service, 2009. - Won CEO Diversity & Inclusion Award, "Best in Class" Sales Leadership, 2009. - Keynote Speaker, 2010 Device & Diagnostics Sales Training & Development Conference, Scottsdale. -
Global Director Of Marketing- EndovascularMedtronic 2005 - 2006Minneapolis, Mn, UsResponsible for leading upstream, downstream, market development, and physician education marketing teams for $220M global AAA/TAA business with a strong focus on global therapy adoption and leading through US regulatory gaps. - Lead team of 20+ marketing and physician training personnel to design and execute strategic plans for existing and new products to maximize revenue, share, therapy penetration, and market growth. - Developed and managed Scientific Physician Advisory Board and WW KOL relationships. - Directed strategic planning, grants and donations process, trade show promotion, and FDA mandated physician training and compliance programs in support of key business objectives. - Successfully launched Valiant Thoracic (OUS), AneuRx AAAdvantage, and Reliant Balloon (US) to capture #1 share positions and margin improvements (88%). Valiant became most profitable product line in Medtronic at launch and grew EU thoracic business 92% in first year. - Screened 20,000 patients for AAA & PVD in partnership with Life Line Screening, Inc and collected data to support lobbying for passage of the SAAAVE Act by Congress to accelerate diagnosis and treatment of AAA disease. - Launched Medtronic Vascular Fellows Program and StentGraftTracker service to aid patient follow up. - Global business grew from $200 to over $600m during my tenure as a commercial functional leader at Medtronic.
-
Director Of Global Product Management- EndovascularMedtronic 2004 - 2005Minneapolis, Mn, UsDirected upstream & downstream product management teams for AAA/TAA business. - Initiated game changing Endurant and Valiant product development process after gathering key internal and external customer inputs and redirecting portfolio focus. Both devices in 2014 still command close to 50% share of the global endograft market. - Developed strategy to reintroduce maturing core product AneuRx through cadence of new product iterations and rebranding. Reversed market share erosion and grew 16% in first year of launch. - Member of strategic planning team that designed product development prioritization model widely adopted pan MDT.
-
Sr Product Manager- Aaa Stent GraftsMedtronic 2003 - 2004Minneapolis, Mn, UsSelected for first sales & marketing rotation under the leadership of Pat Mackin and Bill Hawkins.- Defined and guided development and launch of Xcelerant, a common delivery system platform for all current and future MDT stent grafts. Still used today across the MDT portfolio. - Launched and trained OUS sales organizations on Talent AAA Xcelerant.
-
South East Regional Endovascular Sales Manager-Medtronic 2000 - 2003Minneapolis, Mn, UsResponsible for leading eleven sales reps and clinicals in SE Region for AAA business. #1 region in revenue and share. - Regional Manager of the Year- 2001, 2002- President's Club, 2001, 2002
-
Endovascular Sales Representative- North CarolinaMedtronic 1999 - 2000Minneapolis, Mn, UsResponsible for introducing the AneuRx AAA stent graft, a disruptive, first to market new endovascular therapy for abdominal aortic aneurysms. Member of the original AAA sales force. - Sales Representative of the Year- 2000- President's Club- 2000
-
Coronary Diagnostic/Peripheral Sales RepresentativeMedtronic Nov 1998 - Aug 1999Minneapolis, Mn, UsSold peripheral stents and coronary diagnostic products for the fastest growing medical device start up in history at the time. Medtronic purchased AVE for $4.2B in 1999.
-
Regional Sales ManagerAngiodynamics 1996 - 1998Latham, New York, UsManaged half of the US salesforce. Regional Manager of the Year- 1997President's Club- 1997 -
Sales RepresentativeAngiodynamics 1994 - 1996Latham, New York, UsSales Representative of the Year- 1995, 1996President's Club- 1995, 1996Rep of the Quarter- 7 consecutive quartersWon BMW Convertible for being first in company history to reach $1m in territory revenue.
-
Medical Sales RepresentativeNovartis 1992 - 1994Basel, Baselstadt, ChCircle of Merit- 1993 -
District Sales ManagerE&J Gallo Winery 1991 - 1992Modesto, California, UsPiedmont Wine Distributors- Greenville, SC -
Sales RepresentativeE&J Gallo Winery 1990 - 1991Modesto, California, UsNational Sales & Marketing Management Development Program. First in national recruiting class to be promoted to DM.
Brennan Marilla Skills
Medical Devices
Sales Operations
Product Launch
Product Management
Cross Functional Team Leadership
Global Marketing
Market Development
Marketing Strategy
Vascular
Commercialization
Capital Equipment
Sales
Sales Effectiveness
Cardiology
Operating Room
Leadership
Product Development
Marketing
Sales Management
Salesforce.com
Disposables
Strategic Planning
Healthcare
Product Marketing
Surgeons
Change Management
Leading Change
Leading People
Developing Talent
International Marketing
Leading Sales
Leading Large Teams
Organizational Design
Training And Development
Brennan Marilla Education Details
-
North Carolina State UniversityBusiness Management
Frequently Asked Questions about Brennan Marilla
What company does Brennan Marilla work for?
Brennan Marilla works for Ossio, Ltd.
What is Brennan Marilla's role at the current company?
Brennan Marilla's current role is Chief Commercial & Operating Officer at OSSIO.
What is Brennan Marilla's email address?
Brennan Marilla's email address is bm****@****ies.com
What is Brennan Marilla's direct phone number?
Brennan Marilla's direct phone number is +178181*****
What schools did Brennan Marilla attend?
Brennan Marilla attended North Carolina State University.
What are some of Brennan Marilla's interests?
Brennan Marilla has interest in Health, Duke Conference On Leadership 2002, 2004, 2004 Duke Conference On Leadership 2002.
What skills is Brennan Marilla known for?
Brennan Marilla has skills like Medical Devices, Sales Operations, Product Launch, Product Management, Cross Functional Team Leadership, Global Marketing, Market Development, Marketing Strategy, Vascular, Commercialization, Capital Equipment, Sales.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial